The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era

被引：0
|
作者：
Vito Vanella
Lucia Festino
Claudia Trojaniello
Maria Grazia Vitale
Antonio Sorrentino
Miriam Paone
Paolo A. Ascierto
机构：
[1] Istituto Nazionale Tumori IRCCS Fondazione G. Pascale,Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics
[2] University Hospital of Udine,Department of Medicine (DAME)
来源：
Current Oncology Reports | 2019年 / 21卷
关键词：
Melanoma; Immunotherapy; Targeted therapy; CTLA-4; PD-1; Ipilimumab; Nivolumab; Pembrolizumab; Vemurafenib; Cobimetinib; Dabrafenib; Trametinib; Encorafenib; Binimetinib; Combination; Sequencing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era
    Vanella, Vito
    Festino, Lucia
    Trojaniello, Claudia
    Vitale, Maria Grazia
    Sorrentino, Antonio
    Paone, Miriam
    Ascierto, Paolo A.
    CURRENT ONCOLOGY REPORTS, 2019, 21 (09)
  • [2] Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients
    Pier Francesco Ferrucci
    Marko Lens
    Emilia Cocorocchio
    Current Oncology Reports, 2021, 23
  • [3] Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients
    Ferrucci, Pier Francesco
    Lens, Marko
    Cocorocchio, Emilia
    CURRENT ONCOLOGY REPORTS, 2021, 23 (12)
  • [4] The potential of BRAF-targeted therapy combined with immunotherapy in melanoma
    Naderi-Azad, Sheida
    Sullivan, Ryan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (02) : 131 - 136
  • [5] Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma
    Eroglu, Zeynep
    Eatrides, Jennifer
    Naqvi, Syeda Mahrukh Hussnain
    Kim, Youngchul
    Rich, Jeani
    Babacan, Nalan Akgul
    Brohl, Andrew S.
    Markowitz, Joseph
    Sarnaik, Amod
    Zager, Jonathan
    Khushalani, Nikhil I.
    Sondak, Vernon K.
    Messina, Jane
    PIGMENT CELL & MELANOMA RESEARCH, 2020, 33 (01) : 86 - 95
  • [6] Resistance to BRAF-targeted therapy in melanoma
    Sullivan, Ryan J.
    Flaherty, Keith T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1297 - 1304
  • [7] What, if Any, Role Is There for BRAF-Targeted Therapy in BRAF-Mutant Melanoma?
    Sullivan, Ryan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (36) : 4161 - +
  • [8] The Role of BPTF in Melanoma Progression and in Response to BRAF-Targeted Therapy
    Dar, Altaf A.
    Nosrati, Mehdi
    Bezrookove, Vladimir
    de Semir, David
    Majid, Shahana
    Thummala, Suresh
    Sun, Vera
    Tong, Schuyler
    Leong, Stanley P. L.
    Minor, David
    Billings, Paul R.
    Soroceanu, Liliana
    Debs, Robert
    Miller, James R., III
    Sagebiel, Richard W.
    Kashani-Sabet, Mohammed
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (05):
  • [9] Prognostic Clinical and Radiographic Biomarkers for BRAF-Targeted Therapy in Advanced Melanoma
    Shah, Kaustav P.
    Song, Haocan
    Ye, Fei
    Johnson, Douglas B.
    ONCOLOGIST, 2021, 26 (02): : E333 - E335
  • [10] BRAF-targeted therapy and immune responses to melanoma
    Ngiow, Shin Foong
    Knight, Deborah A.
    Ribas, Antoni
    McArthur, Grant A.
    Smyth, Mark J.
    ONCOIMMUNOLOGY, 2013, 2 (06)
12345